phase 2_3_completion
saveAnthem Biosciences Ltd — berubicin hydrochloride (Phase II/III Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: Glioblastoma Multiforme (GBM), Recurrent Glioblastoma Multiforme (GBM)
Therapy area: Oncology. Indication: Glioblastoma Multiforme (GBM), Recurrent Glioblastoma Multiforme (GBM)